Market guru Anil Singhvi has unveiled his Santa pick for 2024 with strong fundamentals and promising growth prospects over the next one to two years. Backed by strategic insights and analyst ratings, these recommendation is tailored for investors seeking decent upside of over 50%.

Key Highlights

  1. Leading Position in US Healthcare Outsourcing
    Sagility is a major player in the US healthcare outsourcing industry. Its strong domain expertise and long-standing client relationships make it a trusted partner in the sector.
  2. Consistent Operational Performance
    The company has delivered steady operational margins in the range of sixteen to eighteen percent, reflecting efficient cost management and strategic execution.
  3. Impressive Growth Outlook
    Sagility is poised to grow at a compounded annual growth rate (CAGR) of fifty per cent in profit after tax (PAT) over the next three years, supported by rising demand and strategic initiatives.
  4. Analyst Ratings

    • JP Morgan: Initiated coverage with an "Overweight" rating, setting a target price of Rs 54.
    • Jefferies: Assigned a "Buy" rating with a target price of Rs 52.

Why Consider Sagility?

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The company is well-positioned to capitalise on the increasing demand for healthcare outsourcing services in the US. Its strong fundamentals, coupled with positive analyst ratings, underline its potential for substantial returns.

Investment Horizon
This stock is ideal for investors with a medium- to long-term perspective, aiming to benefit from its anticipated robust growth trajectory.

Sagility's combination of strong operational performance, industry leadership, and favourable growth outlook makes it a compelling choice in the healthcare outsourcing domain.